KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,583,000 | +53.5% | 20,161 | -12.3% | 0.00% | +100.0% |
| Q4 2016 | $1,031,000 | -55.7% | 22,997 | -50.6% | 0.00% | -66.7% |
| Q2 2016 | $2,328,000 | +8.9% | 46,550 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $2,137,000 | -25.5% | 46,550 | 0.0% | 0.01% | -16.7% |
| Q4 2015 | $2,868,000 | +10.6% | 46,550 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $2,592,000 | -8.7% | 46,550 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $2,838,000 | +5.7% | 46,550 | 0.0% | 0.01% | +20.0% |
| Q1 2015 | $2,685,000 | 0.0% | 46,550 | 0.0% | 0.01% | -16.7% |
| Q4 2014 | $2,685,000 | +102.3% | 46,550 | 0.0% | 0.01% | +100.0% |
| Q3 2014 | $1,327,000 | – | 46,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|